• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
  

PubMed=20687223; DOI=10.1002/pros.21185
Keitaro Kojima, Yasunori Fujita, Yoshinori Nozawa, Takashi Deguchi, Masafumi Ito;
MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
Prostate 70:1501-1512(2010)

PubMed=23876400; DOI=10.1016/j.cyto.2013.06.313
Taku Kato, Yasunori Fujita, Keita Nakane, Kosuke Mizutani, Riyako Terazawa, Hidetoshi Ehara, Yusuke Kanimoto, Toshio Kojima, Yoshinori Nozawa, Takashi Deguchi, Masafumi Ito;
CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling.
Cytokine 64:251-257(2013)

PubMed=27687545; DOI=10.1016/j.bbrc.2016.09.128
Sayaka Sobue, Naoki Mizutani, Yuka Aoyama, Yoshiyuki Kawamoto, Motoshi Suzuki, Yoshinori Nozawa, Masatoshi Ichihara, Takashi Murate;
Mechanism of paclitaxel resistance in a human prostate cancer cell line, PC3-PR, and its sensitization by cabazitaxel.
Biochem. Biophys. Res. Commun. 479:808-813(2016)